Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 28, 2005; 11(12): 1854-1858
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1854
Table 5 Correlation of GF in the course of IFNα2b with RBV therapy with grade activity of inflammation and fibrosis in the liver in responders (R) and non-responders (NR). Histological classification according to Scheuer[13].
Growth factorInflammation activity, grading
Fibrosis hepatitis,staging
PeriportalIntralobular
HGFRNRr = 0.4, P<0.05r = 0.5, P<0.05
NSNSr = 0.5, P<0.03r = 0.4, P<0.03
EGFRr=–0.6, P<0.003r = –0.5, P<0.01NS
NRNSNSNS
TPORr=0.5, P<0.01r = 0.6, P<0.004r = 0.5, P<0.01
NRNSNSr = 0.4, P<0.04
PDGFRr=–0.5, P<0.01r = –0.5, P<0.02NS
NRNSNSNS